
Dr Bird of Sheffield University is the first researcher in the UK to use human tissue models for the study of liver metastasis, where cells from an original cancer tumour spread to the liver and new tumours start to grow. Colorectal cancer (cancer of the lower part of the alimentary canal, or digestive tract) is the second most common malignant cancer in the UK with approximately 29,000 new cases each year. About 15,000 people die each year from cancer of the colon, mostly as a result of tumours developing in the liver.
With the support of the Lord Dowding Fund, Dr Bird is investigating the interaction between liver endothelial cells and tumour cells. This will allow better understanding of how tumours spread from the colon to the liver so that a suitable therapy may be developed. Animal cells and unsuitable human umbilical cord cells have previously been used for these investigations by other researchers. However, at the Royal Hallamshire Hospital where Dr Bird is based, partial hepatectomy operations are regularly carried out as treatment for metastatic liver disease, where sections of the liver containing tumours are removed from the patient. Due to the structure of the liver whole sections must be cut away rather than just the tumour, thereby giving Dr Bird access to the excess healthy liver tissue literally seconds after it is removed from the patient.
Using the liver tissue, Dr Bird has already established a bank of cultured liver cells, which may now be used to research the mechanisms of tumour formation. Previously, Dr Bird established an in vitro model of the gall bladder for cancer research investigations. The Home Office has identified animal research for metastasis in cancer as involving substantial pain. It is therefore hoped that by setting the precedent, of using human tissue, Dr Bird will encourage other researchers to follow suit.
Please help us end the abuse of animals, please make a donation today…
action alerts